Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/cei.12584 http://scihub22266oqcxt.onion/10.1111/cei.12584 C4449776!4449776!25605519     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Exp+Immunol 2015 ; 180 (3): 475-83 Nephropedia Template TP {{tp|p=25605519|t=2015. C1 inhibitor deficiency: 2014 United Kingdom consensus document |pdf=|usr=}}{{25605519}} gab.com Text C1 inhibitor deficiency: 2014 United Kingdom consensus document JO: Clin Exp Immunol http://www.kidney.de/pget.php?&tw=1&pmid=25605519 #FOAvip C1 inhibitor deficiency is a rare disorder manifesting with recurrent attacks of disabling and potentially life-threatening angioedema. Here we present an updated 2014 United Kingdom consensus document for the management of C1 inhibitor-deficient patients, representing a joint venture between the United Kingdom Primary Immunodeficiency Network and Hereditary Angioedema UK. To develop the consensus, we assembled a multi-disciplinary steering group of clinicians, nurses and a patient representative. This steering group first met in 2012, developing a total of 48 recommendations across 11 themes. The statements were distributed to relevant clinicians and a representative group of patients to be scored for agreement on a Likert scale. All 48 statements achieved a high degree of consensus, indicating strong alignment of opinion. The recommendations have evolved significantly since the 2005 document, with particularly notable developments including an improved evidence base to guide dosing and indications for acute treatment, greater emphasis on home therapy for acute attacks and a strong focus on service organization. Twit Text FOAVip C1 inhibitor deficiency: 2014 United Kingdom consensus document ????Clin Exp Immunol http://www.kidney.de/pget.php?&tw=1&pmid=25605519 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25605519 #FOAvip English Wikipedia <ref>{{Cite pmid|25605519}}</ref> C1 inhibitor deficiency: 2014 United Kingdom consensus document #MMPMID25605519 Longhurst HJ; Tarzi MD; Ashworth F; Bethune C; Cale C; Dempster J; Gompels M; Jolles S; Seneviratne S; Symons C; Price A; Edgar D Clin Exp Immunol 2015[Jun]; 180 (3): 475-83 PMID25605519show ga C1 inhibitor deficiency is a rare disorder manifesting with recurrent attacks of disabling and potentially life-threatening angioedema. Here we present an updated 2014 United Kingdom consensus document for the management of C1 inhibitor-deficient patients, representing a joint venture between the United Kingdom Primary Immunodeficiency Network and Hereditary Angioedema UK. To develop the consensus, we assembled a multi-disciplinary steering group of clinicians, nurses and a patient representative. This steering group first met in 2012, developing a total of 48 recommendations across 11 themes. The statements were distributed to relevant clinicians and a representative group of patients to be scored for agreement on a Likert scale. All 48 statements achieved a high degree of consensus, indicating strong alignment of opinion. The recommendations have evolved significantly since the 2005 document, with particularly notable developments including an improved evidence base to guide dosing and indications for acute treatment, greater emphasis on home therapy for acute attacks and a strong focus on service organization. äC1 inhibitor deficiency: 2014 United Kingdom consensus document (epmc).pdf DeepDyve Pubget Overpricing